PNB Vesper completes Phase 2 of clinical trials of GPP-Baladol on COVID-19 patients EP News Bureau Feb 12, 2021 Clinical trial report to be submitted to Drug Controller General of India on February 22, 2021
PNB Vesper to commence phase II clinical trial of COVID-19 drug in BJ Medical College, Pune Usha Sharma Oct 24, 2020 The company has already patented the molecule and secured intellectual property rights in the US, Europe and rest of the world
